作者: Lauren A. Mauro , Joseph M. Herman , Elizabeth M. Jaffee , Daniel A. Laheru
DOI: 10.1016/B978-1-4557-2865-7.00081-3
关键词:
摘要: Abstract Pancreas adenocarcinoma is now the 10th-leading cause of cancer in United States but fourth leading cancer-related death. By 2030, it expected to be second-leading death after lung cancer. Understanding genetics, molecular biology, and immunology pancreas has been key making inroads developing new therapies. This chapter highlights recent progress.